Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Minichromosome Maintenance Complex Component 8
Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Reliability of clinical diagnosis of masses of the cerebellopontine angle: A retrospective multi-institutional study.
Biochemical identification and immunolocalizaton of aggrecan, ADAMTS5 and inter-alpha-trypsin-inhibitor in equine degenerative suspensory ligament desmitis.
Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
View in:
PubMed
subject areas
Autoantibodies
Autoantigens
Autoimmune Diseases
Humans
Immunosuppressive Agents
Molecular Targeted Therapy
Pemphigoid, Bullous
Pemphigus
Skin Diseases, Vesiculobullous
authors with profiles
Kyle Amber